1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Study completion pushed from Jun 2026 to May 2027
AHS Cancer Control AlbertaNot applicable NCT04765241 Registry history of NCT04765241 on ClinicalTrials.gov (opens the registry)
Updated
| Early Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 2 | 25 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05407987 | Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced… | Gynecologic Cancer | Recruiting | 2025-04-25 |
| Phase 2/3 | ||||
| NCT06337695 | Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer | IrAE | Recruiting | 2026-08-27 |
| Phase 2 | ||||
| NCT07578519 | Radiation Treatment of the Prostate That is Specially Adjusted for Each Person | Prostate Cancer | Recruiting | 2026-09-03 |
| NCT06860542 | Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor… | Pneumonitis | Recruiting | 2026-08-07 |
| NCT04765514 | Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients | Glioblastoma Multiforme | Recruiting | 2026-02-13 |
| NCT05421416 | Loratadine for the Prevention of G-CSF-related Bone Pain | Stem Cell Transplant Complications | Recruiting | 2026-02-05 |
| NCT02297217 | Chemoradiotherapy for Advanced Esophageal Cancer | Esophageal Cancer | Recruiting | 2025-12-16 |
| NCT04268199 | A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the… | Myeloma | Recruiting | 2025-12-15 |
| NCT05040815 | Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer | Anal Canal Cancer | Recruiting | 2025-10-02 |
| NCT05663775 | Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab… | Immune-related Adverse Event | Recruiting | 2025-06-27 |
| NCT05775146 | SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With… | Colorectal Cancer | Recruiting | 2025-06-27 |
| NCT04242589 | Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic… | Spinal Metastases | Recruiting | 2025-06-26 |
| NCT04765098 | Tamoxifen Versus Etoposide After First Recurrence in GBM Patients | Glioblastoma Multiforme | Recruiting | 2025-06-26 |
| NCT05451043 | Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for… | Pancreatic Cancer | Recruiting | 2025-06-26 |
| NCT04354649 | Immune-Mediated Pathophysiology And Clinical Triage Program | Arthritis | Recruiting | 2025-06-18 |
| NCT04952480 | Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer | Small Cell Lung Cancer | Recruiting | 2025-06-12 |
| NCT05379712 | Nutritional Supplementation in Head and Neck Cancers | Malnourishment | Recruiting | 2025-03-28 |
| NCT05358262 | High Heated Humidity in Stem Cell Transplant | Autologous Stem Cell Transplant | Recruiting | 2025-01-30 |
| NCT06790589 | COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced… | Advanced Differentiated Thyroid Gland Carcinoma | Not Yet Recruiting | 2026-02-06 |
| NCT07330583 | Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic… | Esophageal Cancer | Not Yet Recruiting | 2026-01-09 |
| NCT07291557 | PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer | Prostate Cancer | Not Yet Recruiting | 2025-12-18 |
| NCT05128734 | Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative… | Breast Cancer Triple Negative | Not Yet Recruiting | 2025-12-15 |
| NCT06882174 | This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab… | Metastatic Non Small Cell Lung Cancer | Not Yet Recruiting | 2025-12-08 |
| NCT02238808 | A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers | Estrogen Receptor Positive Breast Cancer | Active, Not Recruiting | 2025-06-26 |
| NCT02632305 | A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel… | Unresectable Biliary Tract Cancer | Active, Not Recruiting | 2025-06-26 |
Glioblastoma (4) · Glioma (4) · Breast Cancer (3) · Esophageal Cancer (3) · Lung Cancer (3) · Cholangiocarcinoma (2) · Colorectal Cancer (2) · Head & Neck Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Prostate Cancer (2)